Subscribe

Ivan Horak, MD

Articles by Ivan Horak, MD

Ivan Horak, MD

Ivan Horak, MD, on Early Clinical Efficacy of Allogeneic CD30.CAR EBVST Cell Therapy in Lymphomas

ByIvan Horak, MD

January 13th 2023

The chief medical and scientific officer of Tessa Therapeutics discussed data from the BESTA and CHARIOT studies presented at ASH 2022.

Latest Updated Articles

Trending on CGTlive®

BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again

Regeneron’s Gene Therapy DB-OTO Improves Speech Perception in Children With Otoferlin-Related Hearing Loss

Myrtelle’s Canavan Disease Gene Therapy Effects Significant Decrease in CSF NAA and Increases in Brain Myelin Volume

© 2025 MJH Life Sciences^®

All rights reserved.